In Vitro and In Vivo Long Term Release of Apomorphine From Polymer Matrices.

DOI Web Site Web Site Web Site Web Site View 1 Remaining Hide 57 References
  • Raasch Walter
    Institute of Experimental and Clinical Pharmacology and Toxicology,Medical University of Lübeck,Ratzeburger Allee 160,D-23538 Lübeck,Germany
  • Slotty Carsten
    Institute of Experimental and Clinical Pharmacology and Toxicology,Medical University of Lübeck,Ratzeburger Allee 160,D-23538 Lübeck,Germany
  • Dominiak Peter
    Institute of Experimental and Clinical Pharmacology and Toxicology,Medical University of Lübeck,Ratzeburger Allee 160,D-23538 Lübeck,Germany

Search this article

Abstract

Since apomorphine actually reveals high efficacy in treatment of Parkinson’s disease but only has a very short half life, it is of only limited clinical significance.To overcome this substantial disadvantage, drug application by long term delivery systems could be one possibility.Based on this background, ethylene vinyl acetate polymeric delivery systems were manufactured that differed in size, with either coated or uncoated surfaces, but were similar in apomorphine loading.Release from uncoated polymeric delivery systems followed first order kinetics, whereas coated polymeric delivery systems showed within the first 40 days a period of first order kinetics release, in which the release rate is approximately half that of the uncoated polymeric delivery systems, followed by a zero order kinetics release for more than 130 days with a daily release rate of 3.1 ± 0.2 mg.In vivo release was investigated by determining plasma apomorphine concentrations after implanting polymeric delivery systems into the abdominal cavities of rats.Animals with uncoated polymeric delivery systems exhibited symptoms of an apomorphin overdosage within 20 days after surgery.Using coated polymeric delivery systems, a steady state plasma concentration of 15 ng/ml was observed, which was maintained over a period of 130 days after an initial period of high plasma concentrations.Based on our results, it is concluded that polymeric delivery systems might be an appropriate method for applying apomorphine for the treatment of Parkinson’s disease.

Journal

References(57)*help

See more

Details

Report a problem

Back to top